Structure

Physi-Chem Properties

Molecular Weight:  306.13
Volume:  331.449
LogP:  4.925
LogD:  4.044
LogS:  -4.767
# Rotatable Bonds:  3
TPSA:  46.53
# H-Bond Aceptor:  3
# H-Bond Donor:  1
# Rings:  3
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.672
Synthetic Accessibility Score:  2.522
Fsp3:  0.15
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.798
MDCK Permeability:  1.3995778317621443e-05
Pgp-inhibitor:  0.988
Pgp-substrate:  0.002
Human Intestinal Absorption (HIA):  0.005
20% Bioavailability (F20%):  0.003
30% Bioavailability (F30%):  0.004

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.042
Plasma Protein Binding (PPB):  101.74544525146484%
Volume Distribution (VD):  0.598
Pgp-substrate:  0.45735636353492737%

ADMET: Metabolism

CYP1A2-inhibitor:  0.979
CYP1A2-substrate:  0.144
CYP2C19-inhibitor:  0.944
CYP2C19-substrate:  0.104
CYP2C9-inhibitor:  0.907
CYP2C9-substrate:  0.947
CYP2D6-inhibitor:  0.908
CYP2D6-substrate:  0.692
CYP3A4-inhibitor:  0.801
CYP3A4-substrate:  0.205

ADMET: Excretion

Clearance (CL):  2.665
Half-life (T1/2):  0.205

ADMET: Toxicity

hERG Blockers:  0.162
Human Hepatotoxicity (H-HT):  0.615
Drug-inuced Liver Injury (DILI):  0.504
AMES Toxicity:  0.279
Rat Oral Acute Toxicity:  0.407
Maximum Recommended Daily Dose:  0.66
Skin Sensitization:  0.656
Carcinogencity:  0.823
Eye Corrosion:  0.004
Eye Irritation:  0.801
Respiratory Toxicity:  0.899

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC305355

Natural Product ID:  NPC305355
Common Name*:   Lonchocarpin
IUPAC Name:   (E)-1-(5-hydroxy-2,2-dimethylchromen-6-yl)-3-phenylprop-2-en-1-one
Synonyms:   Lonchocarpin
Standard InCHIKey:  UEXPKLJRGIWQBF-CSKARUKUSA-N
Standard InCHI:  InChI=1S/C20H18O3/c1-20(2)13-12-16-18(23-20)11-9-15(19(16)22)17(21)10-8-14-6-4-3-5-7-14/h3-13,22H,1-2H3/b10-8+
SMILES:  O=C(c1ccc2c(c1O)C=CC(O2)(C)C)/C=C/c1ccccc1
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL457644
PubChem CID:   6283743
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003467] Linear 1,3-diarylpropanoids
        • [CHEMONTID:0001630] Chalcones and dihydrochalcones
          • [CHEMONTID:0003472] 2'-Hydroxychalcones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO30165 Pongamia pinnata Species Fabaceae Eukaryota stem bark Indonesia 1999-SEP PMID[14510596]
NPO30165 Pongamia pinnata Species Fabaceae Eukaryota n.a. stem n.a. PMID[14510596]
NPO30165 Pongamia pinnata Species Fabaceae Eukaryota dry stem n.a. n.a. PMID[25466192]
NPO19856 Millettia pulchra Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[25630222]
NPO30165 Pongamia pinnata Species Fabaceae Eukaryota Roots n.a. n.a. PMID[29482940]
NPO30165 Pongamia pinnata Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO19856 Millettia pulchra Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO4735 Lactuca floridana Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO27634 Scorzoneroides autumnalis Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT154 Individual Protein Mothers against decapentaplegic homolog 3 Homo sapiens Potency n.a. 1122.0 nM PMID[551845]
NPT113 Cell Line RAW264.7 Mus musculus Inhibition = 62.9 % PMID[551846]
NPT50 Individual Protein Tyrosyl-DNA phosphodiesterase 1 Homo sapiens Potency n.a. 8912.5 nM PMID[551845]
NPT50 Individual Protein Tyrosyl-DNA phosphodiesterase 1 Homo sapiens Potency n.a. 7943.3 nM PMID[551845]
NPT365 Individual Protein NAD(P)H dehydrogenase [quinone] 1 Mus musculus Ratio = 1.7 n.a. PMID[551847]
NPT34 Cell Line BV-2 Mus musculus IC50 = 3540.0 nM PMID[551848]
NPT314 Organism Bacillus cereus Bacillus cereus MIC = 2000.0 ug.mL-1 PMID[551844]
NPT314 Organism Bacillus cereus Bacillus cereus MBC = 2000.0 ug ml-1 PMID[551844]
NPT19 Organism Escherichia coli Escherichia coli MIC = 1000.0 ug.mL-1 PMID[551844]
NPT19 Organism Escherichia coli Escherichia coli MBC = 1000.0 ug ml-1 PMID[551844]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MIC = 2000.0 ug.mL-1 PMID[551844]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MBC = 2000.0 ug ml-1 PMID[551844]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 2000.0 ug.mL-1 PMID[551844]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MBC = 2000.0 ug ml-1 PMID[551844]
NPT2 Others Unspecified Potency n.a. 12589.3 nM PMID[551845]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 84.0 % PMID[551847]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. CC50 = 66040.0 nM PMID[551849]
NPT634 Organism Leishmania amazonensis Leishmania amazonensis IC50 = 21750.0 nM PMID[551849]
NPT580 Organism Trypanosoma cruzi Trypanosoma cruzi IC50 = 44530.0 nM PMID[551849]
NPT2 Others Unspecified Ratio CC50/IC50 = 3.03 n.a. PMID[551849]
NPT2 Others Unspecified Ratio CC50/IC50 = 1.48 n.a. PMID[551849]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC305355 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC475680
0.9926 High Similarity NPC147688
0.9926 High Similarity NPC156590
0.9926 High Similarity NPC64908
0.9926 High Similarity NPC118840
0.9926 High Similarity NPC205006
0.9853 High Similarity NPC11561
0.9853 High Similarity NPC226636
0.9852 High Similarity NPC172986
0.9852 High Similarity NPC261227
0.9852 High Similarity NPC235239
0.9852 High Similarity NPC270883
0.9781 High Similarity NPC38219
0.9779 High Similarity NPC110969
0.9779 High Similarity NPC103362
0.9778 High Similarity NPC220062
0.9778 High Similarity NPC96565
0.9778 High Similarity NPC55018
0.9778 High Similarity NPC301217
0.9778 High Similarity NPC303633
0.9778 High Similarity NPC216978
0.971 High Similarity NPC234629
0.971 High Similarity NPC311741
0.9708 High Similarity NPC62840
0.9708 High Similarity NPC214236
0.9708 High Similarity NPC299080
0.9708 High Similarity NPC59739
0.9708 High Similarity NPC144499
0.9708 High Similarity NPC217083
0.9708 High Similarity NPC78803
0.9708 High Similarity NPC293852
0.9706 High Similarity NPC159275
0.9706 High Similarity NPC241100
0.9706 High Similarity NPC69769
0.9706 High Similarity NPC150522
0.9704 High Similarity NPC201395
0.9638 High Similarity NPC106985
0.9638 High Similarity NPC18585
0.9638 High Similarity NPC166138
0.9638 High Similarity NPC219915
0.9635 High Similarity NPC282300
0.9632 High Similarity NPC78913
0.9632 High Similarity NPC217186
0.9632 High Similarity NPC18260
0.9632 High Similarity NPC53181
0.963 High Similarity NPC228661
0.9627 High Similarity NPC151113
0.9571 High Similarity NPC104406
0.9571 High Similarity NPC79469
0.9571 High Similarity NPC237635
0.9571 High Similarity NPC23728
0.9571 High Similarity NPC24673
0.9571 High Similarity NPC201731
0.9571 High Similarity NPC110303
0.9571 High Similarity NPC97716
0.9568 High Similarity NPC278175
0.9568 High Similarity NPC469953
0.9568 High Similarity NPC209040
0.9568 High Similarity NPC257236
0.9565 High Similarity NPC200694
0.9559 High Similarity NPC470668
0.9559 High Similarity NPC470669
0.9556 High Similarity NPC13408
0.9504 High Similarity NPC132592
0.9504 High Similarity NPC272194
0.9504 High Similarity NPC160821
0.9504 High Similarity NPC266572
0.9504 High Similarity NPC6511
0.95 High Similarity NPC475052
0.95 High Similarity NPC124729
0.95 High Similarity NPC83357
0.95 High Similarity NPC176229
0.95 High Similarity NPC267375
0.95 High Similarity NPC301276
0.95 High Similarity NPC214774
0.95 High Similarity NPC470647
0.95 High Similarity NPC54577
0.95 High Similarity NPC312973
0.95 High Similarity NPC111786
0.95 High Similarity NPC195621
0.95 High Similarity NPC20488
0.95 High Similarity NPC88964
0.95 High Similarity NPC246948
0.95 High Similarity NPC67805
0.95 High Similarity NPC477955
0.95 High Similarity NPC142405
0.9496 High Similarity NPC257097
0.9496 High Similarity NPC212932
0.9496 High Similarity NPC9117
0.9496 High Similarity NPC175504
0.9496 High Similarity NPC91560
0.9496 High Similarity NPC221432
0.9496 High Similarity NPC190637
0.9496 High Similarity NPC169591
0.9496 High Similarity NPC68104
0.9496 High Similarity NPC150408
0.9496 High Similarity NPC164980
0.9496 High Similarity NPC149026
0.9496 High Similarity NPC75049
0.9496 High Similarity NPC293053
0.9496 High Similarity NPC24821
0.9496 High Similarity NPC11700
0.9496 High Similarity NPC478086
0.9496 High Similarity NPC39329
0.9496 High Similarity NPC316816
0.9496 High Similarity NPC143896
0.9496 High Similarity NPC214166
0.9496 High Similarity NPC310130
0.9493 High Similarity NPC14871
0.9493 High Similarity NPC3188
0.9489 High Similarity NPC23257
0.9485 High Similarity NPC157855
0.9485 High Similarity NPC317119
0.9485 High Similarity NPC266597
0.9485 High Similarity NPC250266
0.9478 High Similarity NPC57601
0.9437 High Similarity NPC65775
0.9437 High Similarity NPC221868
0.9437 High Similarity NPC37208
0.9437 High Similarity NPC10027
0.9433 High Similarity NPC296998
0.9433 High Similarity NPC473077
0.9433 High Similarity NPC180477
0.9433 High Similarity NPC166757
0.9433 High Similarity NPC283234
0.9433 High Similarity NPC14001
0.9429 High Similarity NPC273538
0.9429 High Similarity NPC319752
0.9429 High Similarity NPC131568
0.9429 High Similarity NPC197252
0.9429 High Similarity NPC236766
0.9429 High Similarity NPC326500
0.9429 High Similarity NPC473013
0.9429 High Similarity NPC216538
0.9429 High Similarity NPC473015
0.9429 High Similarity NPC131579
0.9424 High Similarity NPC148757
0.9424 High Similarity NPC76372
0.9424 High Similarity NPC473042
0.9424 High Similarity NPC32739
0.9424 High Similarity NPC66515
0.9424 High Similarity NPC107572
0.9424 High Similarity NPC324134
0.9424 High Similarity NPC161506
0.9424 High Similarity NPC36181
0.9424 High Similarity NPC147145
0.9424 High Similarity NPC324436
0.9424 High Similarity NPC194432
0.9424 High Similarity NPC167624
0.9424 High Similarity NPC37496
0.9424 High Similarity NPC166934
0.9424 High Similarity NPC220998
0.9424 High Similarity NPC76338
0.9424 High Similarity NPC227579
0.9424 High Similarity NPC228504
0.9424 High Similarity NPC78
0.9424 High Similarity NPC166482
0.9424 High Similarity NPC223500
0.9424 High Similarity NPC328164
0.9424 High Similarity NPC177354
0.9424 High Similarity NPC64915
0.9424 High Similarity NPC10937
0.9424 High Similarity NPC265040
0.9424 High Similarity NPC40833
0.9424 High Similarity NPC125855
0.9424 High Similarity NPC182852
0.9424 High Similarity NPC296917
0.9424 High Similarity NPC1089
0.9424 High Similarity NPC306829
0.942 High Similarity NPC219917
0.942 High Similarity NPC172250
0.942 High Similarity NPC80962
0.942 High Similarity NPC471587
0.942 High Similarity NPC326109
0.942 High Similarity NPC213659
0.942 High Similarity NPC259166
0.942 High Similarity NPC48624
0.942 High Similarity NPC204985
0.942 High Similarity NPC215311
0.942 High Similarity NPC144118
0.9416 High Similarity NPC254168
0.9416 High Similarity NPC21350
0.9416 High Similarity NPC272844
0.9416 High Similarity NPC248995
0.9416 High Similarity NPC124269
0.9416 High Similarity NPC131130
0.9412 High Similarity NPC186838
0.9412 High Similarity NPC29353
0.9412 High Similarity NPC477244
0.9412 High Similarity NPC477242
0.9412 High Similarity NPC124784
0.9412 High Similarity NPC240593
0.9412 High Similarity NPC66349
0.9412 High Similarity NPC1486
0.9412 High Similarity NPC274109
0.9412 High Similarity NPC161196
0.9412 High Similarity NPC231772
0.9412 High Similarity NPC473887
0.9412 High Similarity NPC168105
0.9412 High Similarity NPC127447

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC305355 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9568 High Similarity NPD7410 Clinical (unspecified phase)
0.9429 High Similarity NPD4378 Clinical (unspecified phase)
0.9185 High Similarity NPD1240 Approved
0.9137 High Similarity NPD1549 Phase 2
0.913 High Similarity NPD2796 Approved
0.9065 High Similarity NPD1550 Clinical (unspecified phase)
0.9065 High Similarity NPD1552 Clinical (unspecified phase)
0.9058 High Similarity NPD1510 Phase 2
0.9051 High Similarity NPD1607 Approved
0.8912 High Similarity NPD7411 Suspended
0.8844 High Similarity NPD4380 Phase 2
0.8792 High Similarity NPD2393 Clinical (unspecified phase)
0.8742 High Similarity NPD7075 Discontinued
0.8733 High Similarity NPD8443 Clinical (unspecified phase)
0.8725 High Similarity NPD6801 Discontinued
0.869 High Similarity NPD1511 Approved
0.8667 High Similarity NPD7096 Clinical (unspecified phase)
0.8667 High Similarity NPD7819 Suspended
0.8611 High Similarity NPD3750 Approved
0.8571 High Similarity NPD1512 Approved
0.8562 High Similarity NPD6799 Approved
0.8543 High Similarity NPD2801 Approved
0.8542 High Similarity NPD1243 Approved
0.8542 High Similarity NPD7421 Clinical (unspecified phase)
0.8497 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8477 Intermediate Similarity NPD1934 Approved
0.8431 Intermediate Similarity NPD7768 Phase 2
0.8414 Intermediate Similarity NPD2800 Approved
0.8408 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8377 Intermediate Similarity NPD3749 Approved
0.8344 Intermediate Similarity NPD6599 Discontinued
0.8312 Intermediate Similarity NPD3882 Suspended
0.8276 Intermediate Similarity NPD2344 Approved
0.8264 Intermediate Similarity NPD3748 Approved
0.8264 Intermediate Similarity NPD2799 Discontinued
0.8252 Intermediate Similarity NPD6651 Approved
0.825 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8243 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.8227 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.8227 Intermediate Similarity NPD2313 Discontinued
0.8219 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8217 Intermediate Similarity NPD6959 Discontinued
0.8207 Intermediate Similarity NPD1551 Phase 2
0.8207 Intermediate Similarity NPD2935 Discontinued
0.8146 Intermediate Similarity NPD920 Approved
0.8146 Intermediate Similarity NPD5403 Approved
0.8133 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.8129 Intermediate Similarity NPD3817 Phase 2
0.8129 Intermediate Similarity NPD1203 Approved
0.8082 Intermediate Similarity NPD6100 Approved
0.8082 Intermediate Similarity NPD6099 Approved
0.8075 Intermediate Similarity NPD3818 Discontinued
0.8071 Intermediate Similarity NPD2798 Approved
0.8063 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8063 Intermediate Similarity NPD6166 Phase 2
0.8063 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8054 Intermediate Similarity NPD2309 Approved
0.8049 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.8038 Intermediate Similarity NPD5494 Approved
0.8037 Intermediate Similarity NPD5953 Discontinued
0.8025 Intermediate Similarity NPD7286 Phase 2
0.8014 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.8013 Intermediate Similarity NPD5401 Approved
0.8 Intermediate Similarity NPD2797 Approved
0.7987 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7972 Intermediate Similarity NPD3268 Approved
0.7971 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7971 Intermediate Similarity NPD422 Phase 1
0.7941 Intermediate Similarity NPD1548 Phase 1
0.7937 Intermediate Similarity NPD6232 Discontinued
0.7922 Intermediate Similarity NPD3226 Approved
0.7914 Intermediate Similarity NPD7054 Approved
0.7914 Intermediate Similarity NPD9717 Approved
0.7901 Intermediate Similarity NPD7473 Discontinued
0.7895 Intermediate Similarity NPD2532 Approved
0.7895 Intermediate Similarity NPD2533 Approved
0.7895 Intermediate Similarity NPD2534 Approved
0.7891 Intermediate Similarity NPD4308 Phase 3
0.7891 Intermediate Similarity NPD7033 Discontinued
0.7879 Intermediate Similarity NPD6559 Discontinued
0.7867 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7866 Intermediate Similarity NPD7074 Phase 3
0.7866 Intermediate Similarity NPD7472 Approved
0.7862 Intermediate Similarity NPD943 Approved
0.7848 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7847 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7832 Intermediate Similarity NPD6832 Phase 2
0.7818 Intermediate Similarity NPD6797 Phase 2
0.7785 Intermediate Similarity NPD2346 Discontinued
0.7785 Intermediate Similarity NPD5402 Approved
0.7778 Intermediate Similarity NPD4625 Phase 3
0.7771 Intermediate Similarity NPD7251 Discontinued
0.775 Intermediate Similarity NPD919 Approved
0.7748 Intermediate Similarity NPD4628 Phase 3
0.7725 Intermediate Similarity NPD7808 Phase 3
0.7714 Intermediate Similarity NPD1610 Phase 2
0.7712 Intermediate Similarity NPD7390 Discontinued
0.7708 Intermediate Similarity NPD4908 Phase 1
0.7697 Intermediate Similarity NPD5844 Phase 1
0.7687 Intermediate Similarity NPD5124 Phase 1
0.7687 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7676 Intermediate Similarity NPD3225 Approved
0.766 Intermediate Similarity NPD3972 Approved
0.7654 Intermediate Similarity NPD1247 Approved
0.7651 Intermediate Similarity NPD1729 Discontinued
0.7622 Intermediate Similarity NPD3266 Approved
0.7622 Intermediate Similarity NPD3267 Approved
0.7619 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD4307 Phase 2
0.76 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7586 Intermediate Similarity NPD4360 Phase 2
0.7586 Intermediate Similarity NPD4363 Phase 3
0.7566 Intermediate Similarity NPD2654 Approved
0.7562 Intermediate Similarity NPD4288 Approved
0.7561 Intermediate Similarity NPD3926 Phase 2
0.7554 Intermediate Similarity NPD9545 Approved
0.7543 Intermediate Similarity NPD4361 Phase 2
0.7543 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7536 Intermediate Similarity NPD9493 Approved
0.7535 Intermediate Similarity NPD1608 Approved
0.7532 Intermediate Similarity NPD6585 Discontinued
0.75 Intermediate Similarity NPD1465 Phase 2
0.75 Intermediate Similarity NPD1164 Approved
0.7484 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7483 Intermediate Similarity NPD1296 Phase 2
0.7483 Intermediate Similarity NPD4749 Approved
0.7483 Intermediate Similarity NPD3764 Approved
0.7465 Intermediate Similarity NPD1201 Approved
0.7453 Intermediate Similarity NPD2296 Approved
0.7452 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.745 Intermediate Similarity NPD1933 Approved
0.7445 Intermediate Similarity NPD1241 Discontinued
0.7425 Intermediate Similarity NPD5940 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD7003 Approved
0.7396 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD5049 Phase 3
0.7379 Intermediate Similarity NPD1470 Approved
0.7376 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7375 Intermediate Similarity NPD5889 Approved
0.7375 Intermediate Similarity NPD5890 Approved
0.7368 Intermediate Similarity NPD5408 Approved
0.7368 Intermediate Similarity NPD5404 Approved
0.7368 Intermediate Similarity NPD5405 Approved
0.7368 Intermediate Similarity NPD5406 Approved
0.7365 Intermediate Similarity NPD411 Approved
0.7358 Intermediate Similarity NPD7458 Discontinued
0.7356 Intermediate Similarity NPD4287 Approved
0.7355 Intermediate Similarity NPD2354 Approved
0.7347 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD447 Suspended
0.7333 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7324 Intermediate Similarity NPD17 Approved
0.7322 Intermediate Similarity NPD7584 Approved
0.732 Intermediate Similarity NPD1471 Phase 3
0.732 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7289 Intermediate Similarity NPD5710 Approved
0.7289 Intermediate Similarity NPD5711 Approved
0.7279 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7251 Intermediate Similarity NPD6104 Discontinued
0.725 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7248 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7248 Intermediate Similarity NPD6798 Discontinued
0.7222 Intermediate Similarity NPD7577 Discontinued
0.7219 Intermediate Similarity NPD230 Phase 1
0.7215 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD4662 Approved
0.7215 Intermediate Similarity NPD4661 Approved
0.7211 Intermediate Similarity NPD1019 Discontinued
0.7208 Intermediate Similarity NPD2353 Approved
0.7208 Intermediate Similarity NPD2355 Clinical (unspecified phase)
0.7202 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7192 Intermediate Similarity NPD1876 Approved
0.719 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD7229 Phase 3
0.7172 Intermediate Similarity NPD1481 Phase 2
0.7152 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD3140 Approved
0.7152 Intermediate Similarity NPD1613 Approved
0.7152 Intermediate Similarity NPD3142 Approved
0.7143 Intermediate Similarity NPD4476 Approved
0.7143 Intermediate Similarity NPD4477 Approved
0.7134 Intermediate Similarity NPD3887 Approved
0.7134 Intermediate Similarity NPD3295 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD3751 Discontinued
0.7117 Intermediate Similarity NPD6844 Discontinued
0.7117 Intermediate Similarity NPD6280 Approved
0.7117 Intermediate Similarity NPD6279 Approved
0.7114 Intermediate Similarity NPD1008 Clinical (unspecified phase)
0.7103 Intermediate Similarity NPD1535 Discovery
0.7101 Intermediate Similarity NPD2403 Approved
0.708 Intermediate Similarity NPD74 Approved
0.708 Intermediate Similarity NPD9266 Approved
0.7073 Intermediate Similarity NPD5761 Phase 2
0.7073 Intermediate Similarity NPD5760 Phase 2
0.7069 Intermediate Similarity NPD8312 Approved
0.7069 Intermediate Similarity NPD8313 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data